News:

  3. Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir

Advertise Here
+-+-

User+-

Welcome, Guest.
Please login or register.
 
 
 
Forgot your password?
« previous next »
Pages: [1]

Author Topic: Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir  (Read 2006 times)

0 Members and 48 Guests are viewing this topic.

Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
« on: »
Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir.

This study was published on March 3, 2025

Source of information.

1. CIDRAP.

Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
CIDRAP · cidrap.umn.edu
Logged

Share on Bluesky Share on Facebook

Pages: [1]
« previous next »
  3. Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
 


Advertise Here